Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zai Lab (ZLAB) Share-based Compensation (2020 - 2025)

Zai Lab (ZLAB) has disclosed Share-based Compensation for 6 consecutive years, with $15.9 million as the latest value for Q4 2025.

  • Quarterly Share-based Compensation fell 7.75% to $15.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $65.6 million through Dec 2025, down 7.15% year-over-year, with the annual reading at $65.6 million for FY2025, 7.15% down from the prior year.
  • Share-based Compensation hit $15.9 million in Q4 2025 for Zai Lab, down from $16.9 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $22.0 million in Q3 2023 to a low of $7.3 million in Q1 2021.
  • Historically, Share-based Compensation has averaged $15.9 million across 5 years, with a median of $16.7 million in 2023.
  • Biggest five-year swings in Share-based Compensation: surged 184.93% in 2021 and later dropped 23.63% in 2024.
  • Year by year, Share-based Compensation stood at $12.6 million in 2021, then rose by 23.41% to $15.6 million in 2022, then surged by 31.56% to $20.5 million in 2023, then fell by 15.79% to $17.2 million in 2024, then dropped by 7.75% to $15.9 million in 2025.
  • Business Quant data shows Share-based Compensation for ZLAB at $15.9 million in Q4 2025, $16.9 million in Q3 2025, and $17.0 million in Q2 2025.